High-throughput quantification of ochronotic pigment formation in Escherichia coli to evaluate the potency of human 4-hydroxyphenylpyruvate dioxygenase inhibitors in multi-well format

4-hydroxyphenylpyruvate dioxygenase (HPD) is a key enzyme in the catabolism of tyrosine and therefore of great importance as a drug target to treat tyrosine-related inherited metabolic disorders (TIMD). Inhibition of this enzyme is therapeutically applied to prevent accumulation of toxic metabolites...

Descripción completa

Detalles Bibliográficos
Autores principales: Neuckermans, Jessie, Lequeue, Sien, Mertens, Alan, Branson, Steven, Schwaneberg, Ulrich, De Kock, Joery
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Method Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749435/
https://www.ncbi.nlm.nih.gov/pubmed/33365261
http://dx.doi.org/10.1016/j.mex.2020.101181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749435/
https://www.ncbi.nlm.nih.gov/pubmed/33365261
http://dx.doi.org/10.1016/j.mex.2020.101181

Ejemplares similares